These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7965735)

  • 1. Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.
    Brioni JD; O'Neill AB; Kim DJ; Buckley MJ; Decker MW; Arneric SP
    J Pharmacol Exp Ther; 1994 Oct; 271(1):353-61. PubMed ID: 7965735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    Decker MW; Brioni JD; Sullivan JP; Buckley MJ; Radek RJ; Raszkiewicz JL; Kang CH; Kim DJ; Giardina WJ; Wasicak JT
    J Pharmacol Exp Ther; 1994 Jul; 270(1):319-28. PubMed ID: 7913497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
    J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABT-418: discriminative stimulus properties and effect on ventral tegmental cell activity.
    Brioni JD; Kim DJ; Brodie MS; Decker MW; Arneric SP
    Psychopharmacology (Berl); 1995 Jun; 119(4):368-75. PubMed ID: 7480515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties.
    Lin NH; Gunn DE; Ryther KB; Garvey DS; Donnelly-Roberts DL; Decker MW; Brioni JD; Buckley MJ; Rodrigues AD; Marsh KG; Anderson DJ; Buccafusco JJ; Prendergast MA; Sullivan JP; Williams M; Arneric SP; Holladay MW
    J Med Chem; 1997 Jan; 40(3):385-90. PubMed ID: 9022806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization.
    Bannon AW; Decker MW; Curzon P; Buckley MJ; Kim DJ; Radek RJ; Lynch JK; Wasicak JT; Lin NH; Arnold WH; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):787-94. PubMed ID: 9580627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of [3H]ABT-418: a novel cholinergic channel ligand.
    Anderson DJ; Williams M; Pauly JR; Raszkiewicz JL; Campbell JE; Rotert G; Surber B; Thomas SB; Wasicak J; Arneric SP
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1434-41. PubMed ID: 7791118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
    Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys.
    Decker MW; Bannon AW; Curzon P; Gunther KL; Brioni JD; Holladay MW; Lin NH; Li Y; Daanen JF; Buccafusco JJ; Prendergast MA; Jackson WJ; Arneric SP
    J Pharmacol Exp Ther; 1997 Oct; 283(1):247-58. PubMed ID: 9336330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats.
    Zarrindast MR; Solati J; Oryan S; Parivar K
    Pharmacology; 2008; 82(4):276-84. PubMed ID: 18849647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties.
    Arneric SP; Sullivan JP; Decker MW; Brioni JD; Bannon AW; Briggs CA; Donnelly-Roberts D; Radek RJ; Marsh KC; Kyncl J
    Alzheimer Dis Assoc Disord; 1995; 9 Suppl 2():50-61. PubMed ID: 8534424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.
    Revel L; Mennuni L; Garofalo P; Makovec F
    Behav Pharmacol; 1998 May; 9(3):183-94. PubMed ID: 9832933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
    Rodrigues AD; Ferrero JL; Amann MT; Rotert GA; Cepa SP; Surber BW; Machinist JM; Tich NR; Sullivan JP; Garvey DS
    Drug Metab Dispos; 1994; 22(5):788-98. PubMed ID: 7530622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine-induced anxiolytic-like effect in morphine-sensitized mice: involvement of ventral hippocampal nicotinic acetylcholine receptors.
    Rezayof A; Assadpour S; Alijanpour S
    Pharmacol Biochem Behav; 2013 Jan; 103(3):460-6. PubMed ID: 23067878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effect of Copaifera reticulata Ducke copaiba oil in rats tested in the elevated plus-maze: an ethological analysis.
    Curio M; Jacone H; Perrut J; Pinto AC; Filho VF; Silva RC
    J Pharm Pharmacol; 2009 Aug; 61(8):1105-10. PubMed ID: 19703355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine and pentylenetetrazole given post-trial 1 enhance one-trial tolerance to the anxiolytic effect of diazepam in the elevated plus-maze in mice.
    Vargas KM; Da Cunha C; Andreatini R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1394-402. PubMed ID: 16828217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the medial septum cholinoceptors in anxiogenic-like effects of nicotine.
    Zarrindast MR; Tajik R; Ebrahimi-Ghiri M; Nasehi M; Rezayof A
    Physiol Behav; 2013 Jul; 119():103-9. PubMed ID: 23769693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam.
    Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
    Psychopharmacology (Berl); 2002 Jan; 159(2):188-95. PubMed ID: 11862348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressants attenuate both the enhanced ethanol intake and ethanol-induced anxiolytic effects in diazepam withdrawn rats.
    Martijena ID; Bustos SG; Bertotto ME; Molina VA
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):119-30. PubMed ID: 15572281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
    Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.